| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Naringenin | Acute Myeloid Leukemia | 3 | PM | 37206002 | 📋 | Naringenin induces the cell apoptosis of acute myeloid leukemia cells by regulating the lncRNA XIST/miR-34a/HDAC1 signaling |
| Naringenin | Acute Myeloid Leukemia | 2 | PM | 36289647 | 📋 | The SIRT2 Pathway Is Involved in the Antiproliferative Effect of Flavanones in Human Leukemia Monocytic THP-1 Cells |
| Naringenin | Acute Myeloid Leukemia | 1 | PM | 26496980 | 📋 | Co-treatment of THP-1 Cells With Naringenin and Curcumin Induces Cell Cycle Arrest and Apoptosis via Numerous Pathways |
| Naringenin | Chronic Myeloid Leukemia | 2 | PM | 38116560 | 📋 | Co-treatment of Naringenin and Ketoprofen-RGD Suppresses Cell Proliferation via Calmodulin/PDE/cAMP/PKA Axis Pathway in Leukemia and Ovarian Cancer Cells |
| Naringenin | Chronic Myeloid Leukemia | 1 | PM | 35028851 | 📋 | Naringenin enhances anti-proliferation effect of 1-ferrocenyl-3-(4-methylsulfonylphenyl) propen-1-one on two different cells via targeting calmodulin signaling pathway |
| Naringenin | Lupus | 1 | PM | 32421738 | 📋 | Naringenin Mitigates Autoimmune Features in Lupus-Prone Mice by Modulation of T-cell Subsets and Cytokines Profile |
| Naringenin | Platelet Aggregation | 1 | PM | 34475824 | 📋 | Naringenin Inhibits Platelet Activation and Arterial Thrombosis Through Inhibition of Phosphoinositide 3-Kinase and Cyclic Nucleotide Signaling |
| Naringenin | Thrombosis | 1 | PM | 34475824 | 📋 | Naringenin Inhibits Platelet Activation and Arterial Thrombosis Through Inhibition of Phosphoinositide 3-Kinase and Cyclic Nucleotide Signaling |
